Constrained and UV-activatable cell-penetrating peptides for intracellular delivery of liposomes.

[1]  Jim Euchner.  Design , 2014, Catalysis from A to Z.

[2]  Gleb B Sukhorukov,et al.  Remote control over guidance and release properties of composite polyelectrolyte based capsules. , 2011, Advanced drug delivery reviews.

[3]  U. Baxa,et al.  Hyperthermia-triggered intracellular delivery of anticancer agent to HER2(+) cells by HER2-specific affibody (ZHER2-GS-Cys)-conjugated thermosensitive liposomes (HER2(+) affisomes). , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[4]  Gonen Ashkenasy,et al.  Light induced drug delivery into cancer cells. , 2011, Biomaterials.

[5]  U. Haberkorn,et al.  The pharmacokinetics of cell-penetrating peptides. , 2010, Molecular pharmaceutics.

[6]  Roland Brock,et al.  Cellular integration of an enzyme-loaded polymersome nanoreactor. , 2010, Angewandte Chemie.

[7]  Y. Hori,et al.  Photocontrolled compound release system using caged antimicrobial peptide. , 2010, Journal of the American Chemical Society.

[8]  M. Perugini,et al.  Self-assembly of peptides into spherical nanoparticles for delivery of hydrophilic moieties to the cytosol. , 2010, ACS nano.

[9]  J. Boyer,et al.  Remote-control photorelease of caged compounds using near-infrared light and upconverting nanoparticles. , 2010, Angewandte Chemie.

[10]  G. Wong,et al.  Arginine‐rich cell‐penetrating peptides , 2010, FEBS letters.

[11]  N. Kaji,et al.  Quantum dots labeling using octa-arginine peptides for imaging of adipose tissue-derived stem cells. , 2010, Biomaterials.

[12]  A. Eggermont,et al.  Hyperthermia and Thermosensitive Liposomes for Improved Delivery of Chemotherapeutic Drugs to Solid Tumors , 2010, Pharmaceutical Research.

[13]  Li Shi,et al.  Designer nanoparticles: incorporating size, shape and triggered release into nanoscale drug carriers , 2010, Expert opinion on drug delivery.

[14]  Wuli Yang,et al.  Study on the Intracellular Fate of Tat Peptide-Conjugated Quantum Dots by Spectroscopic Investigation , 2010, Journal of Fluorescence.

[15]  Roman I. Koning,et al.  Shape and release control of a peptide decorated vesicle through pH sensitive orthogonal supramolecular interactions. , 2009, Journal of the American Chemical Society.

[16]  Malar A. Azagarsamy,et al.  Enzyme-triggered disassembly of dendrimer-based amphiphilic nanocontainers. , 2009, Journal of the American Chemical Society.

[17]  Renjun Pei,et al.  Triggered release of an active peptide conjugate from a DNA device by an orally administrable small molecule. , 2009, Angewandte Chemie.

[18]  Mauro Ferrari,et al.  Nanomedicine—Challenge and Perspectives , 2009 .

[19]  S. Bauer,et al.  Amphiphilic TiO2 nanotube arrays: an actively controllable drug delivery system. , 2009, Journal of the American Chemical Society.

[20]  Juan L. Vivero-Escoto,et al.  Photoinduced intracellular controlled release drug delivery in human cells by gold-capped mesoporous silica nanosphere. , 2009, Journal of the American Chemical Society.

[21]  K. Tachibana,et al.  A novel strategy utilizing ultrasound for antigen delivery in dendritic cell-based cancer immunotherapy. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[22]  G. Fields,et al.  Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. , 2009, International journal of peptide and protein research.

[23]  W. Stüber,et al.  Synthesis of peptide amides by Fmoc-solid-phase peptide synthesis and acid labile anchor groups. , 2009, International journal of peptide and protein research.

[24]  W. Stüber,et al.  Synthesis and application of acid labile anchor groups for the synthesis of peptide amides by Fmoc-solid-phase peptide synthesis. , 2009, International journal of peptide and protein research.

[25]  H. Devalapally,et al.  Multi-functional nanocarriers for targeted delivery of drugs and genes. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[26]  Andrea J. Hanson,et al.  Mechanistic studies of the triggered release of liposomal contents by matrix metalloproteinase-9. , 2008, Journal of the American Chemical Society.

[27]  Zhuang Liu,et al.  PEGylated nanographene oxide for delivery of water-insoluble cancer drugs. , 2008, Journal of the American Chemical Society.

[28]  H. Dai,et al.  Targeted single-wall carbon nanotube-mediated Pt(IV) prodrug delivery using folate as a homing device. , 2008, Journal of the American Chemical Society.

[29]  S. Kelley,et al.  Cell-penetrating peptides as delivery vehicles for biology and medicine. , 2008, Organic & biomolecular chemistry.

[30]  S. Ganta,et al.  A review of stimuli-responsive nanocarriers for drug and gene delivery. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[31]  S. Futaki,et al.  Cellular internalization and distribution of arginine-rich peptides as a function of extracellular peptide concentration, serum, and plasma membrane associated proteoglycans. , 2008, Bioconjugate chemistry.

[32]  William R. Dichtel,et al.  Enzyme-responsive snap-top covered silica nanocontainers. , 2008, Journal of the American Chemical Society.

[33]  V. Torchilin,et al.  Tatp-mediated intracellular delivery of pharmaceutical nanocarriers. , 2007, Biochemical Society transactions.

[34]  W. Jiskoot,et al.  Cytosolic Delivery of Liposomally Targeted Proteins Induced by Photochemical Internalization , 2007, Pharmaceutical Research.

[35]  S. Libutti,et al.  Pulsed-High Intensity Focused Ultrasound and Low Temperature–Sensitive Liposomes for Enhanced Targeted Drug Delivery and Antitumor Effect , 2007, Clinical Cancer Research.

[36]  Jeffrey I. Zink,et al.  Photo-Driven Expulsion of Molecules from Mesostructured Silica Nanoparticles , 2007 .

[37]  Dominic J. Glover,et al.  Histone-mediated transduction as an efficient means for gene delivery. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[38]  V. Torchilin,et al.  Design, synthesis, and characterization of pH-sensitive PEG-PE conjugates for stimuli-sensitive pharmaceutical nanocarriers: the effect of substitutes at the hydrazone linkage on the ph stability of PEG-PE conjugates. , 2007, Bioconjugate chemistry.

[39]  J. F. Stoddart,et al.  Design and optimization of molecular nanovalves based on redox-switchable bistable rotaxanes. , 2007, Journal of the American Chemical Society.

[40]  Vladimir P Torchilin,et al.  Enhanced transfection of tumor cells in vivo using “Smart” pH-sensitive TAT-modified pegylated liposomes , 2007, Journal of drug targeting.

[41]  S. Frokjaer,et al.  Phospholipase A2 Sensitive Liposomes for Delivery of Small Interfering RNA (siRNA) , 2007, Journal of liposome research.

[42]  V. Torchilin,et al.  “Smart” Drug Carriers: PEGylated TATp-Modified pH-Sensitive Liposomes , 2007, Journal of liposome research.

[43]  D. Schmaljohann.  Thermo- and pH-responsive polymers in drug delivery. , 2006, Advanced drug delivery reviews.

[44]  V. Torchilin,et al.  "SMART" drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers. , 2006, Bioconjugate chemistry.

[45]  Rajesh Subramaniam,et al.  Formulation of photocleavable liposomes and the mechanism of their content release. , 2006, Organic & biomolecular chemistry.

[46]  R. Fischer,et al.  Break on through to the Other Side—Biophysics and Cell Biology Shed Light on Cell‐Penetrating Peptides , 2005, Chembiochem : a European journal of chemical biology.

[47]  Victor S-Y Lin,et al.  Stimuli-responsive controlled-release delivery system based on mesoporous silica nanorods capped with magnetic nanoparticles. , 2005, Angewandte Chemie.

[48]  V. Torchilin.  Recent advances with liposomes as pharmaceutical carriers , 2005, Nature Reviews Drug Discovery.

[49]  W. Jiskoot,et al.  OVCAR-3 cells internalize TAT-peptide modified liposomes by endocytosis. , 2004, Biochimica et biophysica acta.

[50]  K. Burgess,et al.  Syntheses and Activities of New C10 β-Turn Peptidomimetics , 2004 .

[51]  A. Kutateladze,et al.  Dithiane-Based Photolabile Amphiphiles: Toward Photolabile Liposomes1,2 , 2003 .

[52]  R. Nolte,et al.  Vesicles and polymerized vesicles from thiophene-containing rod-coil block copolymers. , 2003, Angewandte Chemie.

[53]  W. Jiskoot,et al.  Functional Characterization of an Endosome-disruptive Peptide and Its Application in Cytosolic Delivery of Immunoliposome-entrapped Proteins* , 2002, The Journal of Biological Chemistry.

[54]  L. Chaloin,et al.  Improvement of porphyrin cellular delivery and activity by conjugation to a carrier peptide. , 2001, Bioconjugate chemistry.

[55]  V. Torchilin,et al.  TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[56]  F. Muggia,et al.  Liposomal encapsulated anthracyclines: new therapeutic horizons , 2001, Current oncology reports.

[57]  F. Szoka,et al.  Cholesterol phosphate derivatives: synthesis and incorporation into a phosphatase and calcium-sensitive triggered release liposome. , 1998, Bioconjugate chemistry.

[58]  N. Mullah,et al.  Poly(ethylene glycol)-grafted liposomes with oligopeptide or oligosaccharide ligands appended to the termini of the polymer chains. , 1997, Bioconjugate chemistry.

[59]  A. Gabizon,et al.  Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[60]  T M Allen,et al.  Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. , 1991, Biochimica et biophysica acta.

[61]  G Gregoriadis,et al.  Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol)-coated vesicles. , 1991, Biochimica et biophysica acta.

[62]  G Blume,et al.  Liposomes for the sustained drug release in vivo. , 1990, Biochimica et biophysica acta.

[63]  Kazuo Maruyama,et al.  Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes , 1990, FEBS letters.

[64]  G. Fields,et al.  Solid Phase Peptide Synthesis Utilizing 9-Fluorenylmethoxycarbonylamino Acids , 1990 .

[65]  Carl O. Pabo,et al.  Cellular uptake of the tat protein from human immunodeficiency virus , 1988, Cell.

[66]  D. Friend,et al.  Endocytosis of liposomes and intracellular fate of encapsulated molecules: Encounter with a low pH compartment after internalization in coated vesicles , 1983, Cell.

[67]  R Blumenthal,et al.  Design of liposomes for enhanced local release of drugs by hyperthermia. , 1978, Science.

[68]  F. Szoka,et al.  Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[69]  S. Fleischer,et al.  Two dimensional thin layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots , 1970, Lipids.

[70]  E. Kaiser,et al.  Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides. , 1970, Analytical biochemistry.

[71]  Tayyaba Hasan,et al.  Intracellular drug delivery by poly(lactic-co-glycolic acid) nanoparticles, revisited. , 2009, Molecular pharmaceutics.

[72]  Xenophon E. Verykios,et al.  A Light-Actuated Nanovalve Derived from a Channel Protein , 2005 .

[73]  K. Burgess,et al.  Syntheses and activities of new C10 beta-turn peptidomimetics. , 2004, The Journal of organic chemistry.

[74]  P. Cullis,et al.  Liposomal doxorubicin. , 1996, Journal of drug targeting.

[75]  M. Green,et al.  Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. , 1988, Cell.

[76]  A. A. Spector,et al.  Binding of long-chain fatty acids to bovine serum albumin. , 1969, Journal of lipid research.